Cite
HARVARD Citation
Ervine, A. et al. (2014). Thyroid transcription factor‐1 (TTF‐1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus. Histopathology. 64 (6), pp. 840-846. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ervine, A. et al. (2014). Thyroid transcription factor‐1 (TTF‐1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus. Histopathology. 64 (6), pp. 840-846. [Online].